MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Non-motor Scales"

  • 2018 International Congress

    Factors Associated with Non-adherence to Pharmacotherapy in Patients with Parkinson´s Disease Who Take Three and More Daily Doses of Dopaminergic Drugs

    I. Straka, M. Škorvánek, M. Grofik, K. Danterová, M. Minár, J. Benetin, P. Valkovič (Bratislava, Slovakia)

    Objective: Study was aimed to detect extent of adherence to pharmacotherapy in patients with Parkinson´s disease (PD) who take three and more daily doses of…
  • 2018 International Congress

    Dyspnea in Parkinson’s disease: A biomarker of disease’s severity?

    G. Baille, T. Perez, F. Machuron, L. Defebvre, C. Chenivesse, C. Moreau (Lille, France)

    Objective: The aim of our study was to determine the prevalence of dyspnea in a monocentric cohort of 153 non-demented PD patients (mean age: 63.9…
  • 2018 International Congress

    The severity of motor symptoms and depression are the higher predictor for the decrease in daily living activities independence in people with Parkinson’s disease

    C. Dionizio Dias, E. Okamoto, C. Miranda, M. d'Alencar, M.E. Piemonte (São Paulo, Brazil)

    Objective: The purpose of this study was to identify among several motor, cognitive and mental measures which has higher power to predict the reduction in…
  • 2018 International Congress

    Prevalence of non-motor symptoms in Parkinson’s disease and its impact on quality of life in a tertiary care center in India

    M. Karri, B. Ramasamy, R. Kalidoss (Coimbatore, India)

    Objective: To study the prevalence of Non-Motor Symptoms (NMS) in Parkinson’s disease (PD) and their impact on health-related quality of life (HRQoL). Background: PD is…
  • 2018 International Congress

    Natural history of RBD in Parkinson´s disease and response to dopaminergic and non-dopaminergic antiparkinsonian treatment

    M. Ruiz-Lopez, V. Bruno, ME. Freitas, R. Rajalingam, A. Chang, S. Fox, A. Lang (Toronto, ON, Canada)

    Objective: To assess the natural history of rapid eye movement sleep behavior disorder (RBD) in patients with Parkinson´s disease (PD) and clarify its response to…
  • 2018 International Congress

    Alteration of the fecal microbiota in Chinese patients with Parkinson’s disease

    Y. Xiaodong, Q. Yiwei, X. Shaoqing, C. Shengdi, X. Qin (Shanghai, China)

    Objective: Emerging evidences suggest that gut microbiota dysbiosis plays a role in Parkinson’s disease (PD). However, the alterations in fecal microbiome in Chinese PD patients…
  • 2018 International Congress

    Non-motor symptoms in patients from the Catalonian Multiple System Atrophy Registry (CMSAR)

    D.M. Giraldo, A. Pérez Soriano, J. Rios Guillermo, E. Muñoz, Y. Compta, J. Pagonabarraga, F. Valldeoriola, J. Hernández-Vara, S. Jauma Classen, V. Puente, C. Pont, N. Caballol, E. Tolosa, A. Bayes, J. Campdelacreu, O. Fabregues, A. Avila, M. Calopa, C. Gaig, N. Fabregat, P. Pastor, M. Aguilar, M. Pujol, L. Planellas, A. Camara, M.J. Marti (Barcelona, Spain)

    Objective: To assess non-motor symptoms (NMS) and their demographic and clinical correlates in MSA patients included in the CMSAR. Background: NMS are an important and…
  • 2018 International Congress

    Total CSF alpha-synuclein is inversely associated with non-motor symptoms in a population of patients with Parkinson’s Disease

    T. Schirinzi, G. Sancesario, G. Di Lazzaro, B. Biticchi, N. Mercuri, S. Bernardini, A. Pisani (Rome, Italy)

    Objective: To evaluate the association between PD non-motor symptoms (NMS) and CSF levels of neurodegeneration-related proteins in a population of PD patients, aimed at identifying…
  • 2018 International Congress

    Non-motor symptoms in patients with idiopathic and converted REM Sleep Behavior Disorder

    P. Chan, W. Mao, XN. Liu, SQ. Zhan, H. Zhang, Y. Li (Beijing, China)

    Objective: We aimed to extend the evaluations of NMS in idiopathic RBD patients, Parkinson’s disease(PD) and multiple system atrophy(MSA) patients with RBD symptom occurring in…
  • 2018 International Congress

    Risk estimation in the years preceding diagnosis of Parkinson’s disease in the PREDICT-PD cohort

    S. Auger, D. Rack, J. Bestwick, G. Giovannoni, A. Lees, A. Schrag, A. Noyce (London, United Kingdom)

    Objective: To test and refine the use of probability-based algorithms to identify individuals at high-risk of developing Parkinson’s disease (PD). Background: Neurodegeneration preceding a formal…
  • « Previous Page
  • 1
  • …
  • 35
  • 36
  • 37
  • 38
  • 39
  • …
  • 51
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • #25062 (not found)
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley